TrialClinical and experimental nephrology2024

Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial).

Kandai Nozu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.